Fez1/Lzts1 a new mitotic regulator implicated in cancer development
2007

The Role of FEZ1/LZTS1 in Cancer Development

Sample size: 220 publication Evidence: moderate

Author Information

Author(s): Vecchione Andrea, Croce Carlo M, Baldassarre Gustavo

Primary Institution: Ohio State University

Hypothesis

FEZ1/LZTS1 is a new mitotic regulator implicated in cancer development.

Conclusion

The study suggests that loss of LZTS1 is a frequent event in cancer development and progression, leading to chromosomal instability.

Supporting Evidence

  • LZTS1 protein expression is absent or reduced in many cancers compared to non-cancerous tissue.
  • Loss of LZTS1 is associated with tumor grade in bladder cancer.
  • Reintroduction of LZTS1 in cancer cells inhibits tumor growth.
  • LZTS1 knockout mice developed multiple tumors, indicating its role as a tumor suppressor.

Takeaway

This study found that a protein called LZTS1 helps control how cells divide, and when it's missing, it can lead to cancer.

Methodology

The study involved genetic analysis of cancer samples and experimental studies using cancer cell lines.

Limitations

The study primarily focuses on specific cancer types and may not generalize to all cancers.

Participant Demographics

The study analyzed various cancer types including esophageal, prostate, gastric, and breast cancers.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1747-1028-2-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication